Charles River Laboratories Announces Chief Financial Officer Transition

Core Points - Charles River Laboratories announced the resignation of CFO Flavia H. Pease, effective September 29, 2025, and appointed Michael G. Knell as interim CFO while a search for a permanent successor is conducted [1][2] - The company reaffirmed its financial guidance for 2025, including revenue and non-GAAP earnings per share, based on its current outlook for third-quarter performance [3] Management Transition - Flavia H. Pease contributed significantly during her three years at the company, helping to navigate challenging demand environments and optimize cost structures [2] - Michael G. Knell, who has been with the company since 2017, is expected to lead the finance organization effectively during the interim period [2] Financial Guidance - The company maintains its previously provided financial guidance for 2025, indicating confidence in its revenue and earnings projections [3]